Yahoo Finance 
Global In Silico Clinical Trials Market Report 2022: Increasing Instances of Communicable and Non-Communicable Diseases to Propel Growth
Global In Silico Clinical Trials Market
Dublin, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The "Global In Silico Clinical Trials Market, By Industry (Medical Devices v/s Pharmaceuticals), By Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases, Orthopedic, Dermatology, Others), By Region, Competition Forecast and Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.
The Global in Silico Clinical Trials Market was valued to be USD2743.64 million in the year 2021 and is expected to grow with a CAGR of 12.28% in the forecast period, 2023-2027 to reach a market value of USD5451.19 million by 2027. The market is anticipated to grow on the account of growing demand for clinical trials that are cost-effective, time-efficient, and avoids animal cruelty. In-silico clinical trials satisfy these demands.
Moreover, increasing instances of communicable and non-communicable diseases like cancer, diabetes, cardiovascular diseases, neurological disorders, SARS-CoV-2, among others are further driving the growth of the Global in Silico Clinical Trials Market in the upcoming five years.
Also, growing pharma industry and increased development of the innovative pharmaceutical products as treatment for the growing instances of the diseases is also supporting the growth of the Global in Silico Clinical Trials Market in the next five years. Technological advancements to enhance the rate of successful clinical trials by using computational tools, software and platforms that would support the drug discoveries and latest medical equipment and tools launch is expected to further substantiate the growth of the Global in Silico Clinical Trials Market in the future five years.
Report Scope:
In this report, the Global in Silico Clinical Trials Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
In Silico Clinical Trials Market, By Industry
Medical Devices
Pharmaceuticals
In Silico Clinical Trials Market, By Therapeutic Area
Oncology
Neurology
Cardiology
Infectious Diseases
Orthopedic
Dermatology
Others
In Silico Clinical Trials Market, By Region
North America
United States
Canada
Mexico
Europe
France
Germany
United Kingdom
Italy
Spain
Asia Pacific
Japan
China
Australia
India
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global in Silico Clinical Trials Market.
Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs.
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global In Silico Clinical Trials Market
4. Executive Summary
5. Voice of Customer
6. Global In Silico Clinical Trials Market Outlook, 2017-2027F
7. North America In Silico Clinical Trials Market Outlook, 2017-2027F
8. Europe In Silico Clinical Trials Market Outlook, 2017-2027F
9. Asia-Pacific In Silico Clinical Trials Market Outlook, 2017-2027F
10. South America In Silico Clinical Trials Market Outlook, 2017-2027F
11. Middle East and Africa In Silico Clinical Trials Market Outlook, 2017-2027F
12. Market Dynamics
13. Market Trends & Developments
14. Competitive Landscape
15. Strategic Recommendations
Companies Mentioned
Dassault Systemes SE
Certara Inc.
Insilico Medicine
GNS Healthcare Inc.
The AnyLogic Company
Novadiscovery SAS
InSilicoTrials Technologies SpA
Immunetrics Inc
CATO SMS
Evotec SE
For more information about this report visit https://www.researchandmarkets.com/r/683wln
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
